ASX - By Stock
|
CU6 |
Re:
Industry News: A competitor just got bought out!
|
|
Bran
|
16 |
3.9K |
9 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
16
|
3.9K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
Bran
|
153 |
48K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
153
|
48K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene data published in Cancer Research Journal
|
|
Bran
|
38 |
14K |
138 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
38
|
14K
|
138
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Announces On-Market Share Buyback
|
|
Bran
|
215 |
71K |
65 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
215
|
71K
|
65
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Expanded Heart Protection Discovery for Zantrene
|
|
Bran
|
386 |
131K |
34 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
386
|
131K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Ceasing to be a substantial holder
|
|
Bran
|
40 |
12K |
35 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
40
|
12K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
SPP Survey
|
|
Bran
|
314 |
88K |
2 |
28/11/21 |
28/11/21 |
ASX - By Stock
|
314
|
88K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
SPP Survey
|
|
Bran
|
314 |
88K |
5 |
28/11/21 |
28/11/21 |
ASX - By Stock
|
314
|
88K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
Bran
|
218 |
65K |
18 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
218
|
65K
|
18
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bran
|
20K |
6.9M |
7 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
20K
|
6.9M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race appoints Professor Michael Kelso as Principal Scientist
|
|
Bran
|
24 |
6.9K |
16 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
24
|
6.9K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Preclinical Drug Study Published
|
|
Bran
|
83 |
27K |
30 |
10/05/21 |
10/05/21 |
ASX - By Stock
|
83
|
27K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Race- Buyout or Takeover discussions
|
|
Bran
|
92 |
30K |
13 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
92
|
30K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates Extramedullary AML Preclinical Study
|
|
Bran
|
145 |
38K |
17 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
145
|
38K
|
17
|
|
ASX - By Stock
|
GNM |
Re:
Ann: Capital Raising to accelerate Camel Creek exploration
|
|
Bran
|
24 |
11K |
7 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
24
|
11K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Cleansing Notice
|
|
Bran
|
104 |
24K |
22 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
104
|
24K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Compelling Preclinical Breast Cancer Results
|
|
Bran
|
253 |
82K |
41 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
253
|
82K
|
41
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Compelling Preclinical Breast Cancer Results
|
|
Bran
|
253 |
82K |
26 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
253
|
82K
|
26
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Bran
|
10K |
3.7M |
5 |
26/02/21 |
26/02/21 |
General
|
10K
|
3.7M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bran
|
20K |
6.9M |
19 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
20K
|
6.9M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to recruit new Chief Medical Officer
|
|
Bran
|
93 |
22K |
5 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
93
|
22K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
2.8K |
978K |
5 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.8K
|
978K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
2.8K |
978K |
2 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.8K
|
978K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
2.8K |
978K |
7 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.8K
|
978K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
2.8K |
978K |
5 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.8K
|
978K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
2.8K |
978K |
12 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.8K
|
978K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
2.8K |
978K |
4 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.8K
|
978K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
2.8K |
978K |
14 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.8K
|
978K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
2.8K |
978K |
6 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.8K
|
978K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
2.8K |
978K |
6 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.8K
|
978K
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bran
|
20K |
6.9M |
36 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
20K
|
6.9M
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Bran
|
1.1K |
310K |
7 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Bran
|
1.1K |
310K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Bran
|
1.1K |
310K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Bran
|
10K |
3.7M |
25 |
10/02/21 |
10/02/21 |
General
|
10K
|
3.7M
|
25
|
|
ASX - By Stock
|
RAC |
Re:
RAC Upside - promising forgotten cancer drug that works
|
|
Bran
|
208 |
98K |
11 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
208
|
98K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Congrats!
|
|
Bran
|
6 |
2.2K |
7 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
6
|
2.2K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
The RAC 3-Pillar Trifecta
|
|
Bran
|
424 |
156K |
7 |
06/12/20 |
06/12/20 |
ASX - By Stock
|
424
|
156K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Bran
|
10K |
3.7M |
15 |
01/12/20 |
01/12/20 |
General
|
10K
|
3.7M
|
15
|
|
ASX - By Stock
|
RAC |
Re:
RAC Research Primer - June 2020
|
|
Bran
|
141 |
35K |
7 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
141
|
35K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Extension of time to repay loan through share buy-back
|
|
Bran
|
27 |
7.3K |
4 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
27
|
7.3K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
Bran
|
151 |
39K |
3 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
151
|
39K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Trading Halt
|
|
Bran
|
159 |
88K |
2 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
159
|
88K
|
2
|
|
ASX - By Stock
|
NUH |
Re:
Ann: NUH Partners with Walgreens in US Direct-to-Consumer Hearing
|
|
Bran
|
170 |
81K |
18 |
16/12/19 |
16/12/19 |
ASX - By Stock
|
170
|
81K
|
18
|
|
ASX - By Stock
|
NUH |
Re:
Ann: NUH Partners with Walgreens in US Direct-to-Consumer Hearing
|
|
Bran
|
170 |
81K |
9 |
16/12/19 |
16/12/19 |
ASX - By Stock
|
170
|
81K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y-Dr Daniel Tillett
|
|
Bran
|
8 |
4.1K |
13 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
8
|
4.1K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Prof Borje Andersson to Chair Clinical Advisory Board
|
|
Bran
|
16 |
5.5K |
13 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
16
|
5.5K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
1993: 5 of a total of 7 (72%) patients achieved total eradication of their cancer (R/R AML)
|
|
Bran
|
29 |
11K |
5 |
29/11/19 |
29/11/19 |
ASX - By Stock
|
29
|
11K
|
5
|
|
ASX - By Stock
|
NUH |
Re:
Share Price Rising
|
|
Bran
|
2.0K |
855K |
11 |
21/11/19 |
21/11/19 |
ASX - By Stock
|
2.0K
|
855K
|
11
|
|
ASX - By Stock
|
NUH |
Re:
nuh media thread
|
|
Bran
|
15K |
5.4M |
9 |
12/11/19 |
12/11/19 |
ASX - By Stock
|
15K
|
5.4M
|
9
|
|